Healx
PrivateLast Round
Series C
Aug 1, 2024
Total Funding Raised
$114.9M
Company Overview
Healx is a biotechnology company that utilizes artificial intelligence-driven drug discovery technology to develop treatments for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healx Comparables
Compare Healx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SOM Biotech | 84% | |
| Delta4 | 82% | |
| Purposeful | 82% |
Healx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 1, 2024 | ||||
| Series B | Oct 16, 2019 | ||||
| Series A | Jul 26, 2018 | ||||
| Seed | Oct 4, 2016 |
Healx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amadeus Capital Partners | Series A, Series B, Seed |
| o2h ventures | Series C |
| Global Brain Corporation | Series C, Series B |
| Meltwind Advisory | Seed, Series A, Series B |
| Intel Capital | Series B |
| b2venture | Series C, Series B |
| VU Venture Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
Partnered with Vuja De Sciences to focus on oncology.
- Jul 1, 2025
Drug candidates have entered clinical trials, indicating a clinical-stage development.
Healx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Healx's valuation, stock price, and market status.
Is Healx a public or private company?
Healx is a private company.
What is the current stock price of Healx?
Healx is a private company with no public stock price. No recent secondary market data is available.
How much is Healx worth (valuation)?
Valuation information for Healx is not publicly available.
Can I buy Healx stock?
Healx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Healx's last funding round?
Healx's most recent funding round was Series C on August 1, 2024.
Who are the main investors in Healx?
Key investors in Healx include Amadeus Capital Partners, Atomico, Balderton Capital, R42 Group.
Will Healx IPO soon?
No public IPO plans have been announced for Healx.
How can I track Healx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Healx's secondary market activity and sign up for updates.